BioCardia (BCDA) Notes Payables (2010 - 2022)

BioCardia (BCDA) has reported Notes Payables for 7 consecutive years, with $18000.0 the latest figure, recorded in Q4 2022.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $18000.0 in Q4 2022; TTM through Dec 2022 was $18000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $18000.0, changed N/A from the prior year.
• Notes Payables was $18000.0 for Q4 2022 at BioCardia, up from $14000.0 in the prior quarter.
• Over five years, Notes Payables peaked at $284000.0 in Q3 2020 and troughed at $14000.0 in Q3 2022.
• A 3-year average of $106125.0 and a median of $85000.0 in 2018 frame the typical range for Notes Payables.
• The widest YoY moves for Notes Payables: up 45.16% in 2018, down 33.87% in 2018.
• Over 3 years, Notes Payables stood at $83000.0 in 2018, then jumped by 242.17% to $284000.0 in 2020, then sank by 93.66% to $18000.0 in 2022.
• The last three Notes Payables figures came in at $18000.0 (Q4 2022), $14000.0 (Q3 2022), and $47000.0 (Q2 2022), per Business Quant data.